Hosted by American Conference Institute (ACI), the National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies will highlight leveraging technology, safeguarding IP, and securing funding to accelerate development in mRNA, CRISPR and CAR-T.
ACI is delighted to bring you this new program which is a holistic, end-to-end summit for therapeutic pioneers, innovators, investors, executives and their counsel to meet, assess, and shape the future development and commercialization of these novel modalities and therapies.
We are pleased to announce that confirmed speakers include, Julia Tierney (Chief of Staff, Food and Drug Administration), Anne Gussow (Supervisory Patent Examiner, Quality Assurance Specialist, USPTO), Karlheinz Skowronek (Supervisory Patent Examiner, Bioinformatics, USPTO) and Julie Wu (Supervisory Patent Examiner, Immunotherapy and Recombinant Antibodies, USPTO).
Be part of the discussions that will shape and transform the future of therapeutics. Join us from March 21-22, 2023, in Boston, MA. Visit http://bit.ly/3VPEspR to view this year’s agenda and learn more.

Save 10% with the MassBio promo code: D10-999-MASSBIO